Literature DB >> 3073651

The Roswell Park Memorial Institute and Gastrointestinal Tumor Study Group phase III experience with the modulation of 5-fluorouracil by leucovorin in metastatic colorectal adenocarcinoma.

N J Petrelli1, Y M Rustum, H Bruckner, D Stablein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3073651     DOI: 10.1007/978-1-4684-5607-3_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  Combined Chemotherapy with Mitomycin C, Folinic Acid, and 5-Fluorouracil (MiFoFU) as Salvage Treatment for Patients with Liver Metastases from Breast Cancer - a Retrospective Analysis.

Authors:  Michael H R Eichbaum; Anne-Sybil Gast; Thomas Bruckner; Andreas Schneeweiss; Christof Sohn
Journal:  Breast Care (Basel)       Date:  2008-08-11       Impact factor: 2.860

2.  Pharmacokinetic and pharmacodynamic comparison of two doses of calcium folinate combined with continuous fluorouracil infusion in patients with advanced colorectal cancer.

Authors:  S Stremetzne; M Streit; E D Kreuser; W Schunack; U Jaehde
Journal:  Pharm World Sci       Date:  1999-08

Review 3.  FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer.

Authors:  Saima Sharif; Michael J O'Connell; Greg Yothers; Samia Lopa; Norman Wolmark
Journal:  Cancer Invest       Date:  2008-11       Impact factor: 2.176

4.  Toxicities of chemoradiotherapy and radiotherapy in nasopharyngeal carcinoma: an updated meta-analysis.

Authors:  Chun Wang; Fei Wang; Xin Min; Qinfang Zhang; Li-Juan Shen; Ying Jiang; Jun Yan
Journal:  J Int Med Res       Date:  2019-07-05       Impact factor: 1.671

5.  Tooth Formation as Experimental Model to Study Chemotherapy on Tissue Development: Effect of a Specific Dose of Temozolomide/Veliparib.

Authors:  Sali Al-Ansari; Rozita Jalali; Antonius L J J Bronckers; Olaf van Tellingen; Judith Raber-Durlacher; Nasser Nadjmi; Alan Henry Brook; Jan de Lange; Frederik R Rozema
Journal:  Genes (Basel)       Date:  2022-07-04       Impact factor: 4.141

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.